MBX Biosciences Inc. Common Stock

MBX | NASDAQ

$61.67

+$0.73 (+1.20%)

Sep 22, 2026, 1:17 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Cash & Equivalents	75.29M	49.35M	30.52M	24.21M
Short-Term Investments	298.42M	212.8M	50.15M	18.25M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	383K	50K	50K	42K
Receivables	2.12M	682K	208K	142K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	861K	803K	133K	84K
Total Current Assets	381.54M	267.29M	83.47M	44.21M
Property-Plant & Equipment	3.22M	1.2M	665K	842K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.61M	1.25M	715K	884K
Total Assets	385.14M	268.54M	84.18M	45.1M
Account Payables	2.98M	5.34M	1.39M	976K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	4.32M	2.32M	1.37M	1.13M
Total Current Liabilities	15.5M	11.05M	3.93M	3.43M
Long-Term Debt	424K	n/a	n/a	n/a
Other Long-Term Liabilities	2K	42K	152.55M	83.95M
Total Long-Term Liabilities	426K	42K	152.72M	84.27M
Total Liabilities	15.92M	11.09M	156.65M	87.7M
Total Debt	596K	171K	324K	461K
Book Value	369.22M	257.44M	-72.47M	-42.61M
Book Value Per Share	10.11	7.71	-2.28	-1.34
Common Stock	6K	5K	1K	1K
Retained Earnings	-224.48M	-137.51M	-75.58M	-43.02M
Comprehensive Income	286K	55K	60K	3K
Shareholders Equity	369.22M	257.44M	-72.47M	-42.61M
Total Investments	298.42M	212.8M	50.15M	18.25M